Karl Swartling

Karl Swartling

Nessuna posizione attualmente
61 anni
Finance
Health Technology
Health Services

Profilo

Mr. Karl A. Swartling is a Chief Executive Officer at Stena Sessan AB. He is on the Board of Directors at Affibody AB. Mr. Swartling was previously employed as a Managing Director by Sjätte AP-fonden, a Managing Director by Sjätte AP-fonden (Private Equity), a Managing Director by Investor Growth Capital AB, a Deputy Director by Atlas Antibodies AB, a Non-Executive Director by GHP Specialty Care AB, and a Principal by Mckinsey & Co., Inc. (Munich).
He also served on the board at Aerocrine AB, Cambio Healthcare Systems AB, Cellectricon AB, Global Health Partner Ltd., KTH Holding AB, Mando AB, Newron Sweden AB, PocketMobile Communications AB, Sörman Intressenter AB and Tobii AB. He received his MBA from Stockholm School of Economics.

Posizioni attive di Karl Swartling

SocietàPosizioneInizio
Direttore/Membro del Consiglio -

Precedenti posizioni note di Karl Swartling

SocietàPosizioneFine
Amministratore Delegato 01/03/2019
Amministratore Delegato 01/03/2019
Presidente 21/01/2012
AEROCRINE AB Direttore/Membro del Consiglio 16/11/2011
Mckinsey & Co., Inc. (Munich)
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Karl Swartling

Formazione di Karl Swartling

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

18

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private18

Electronic Technology

Commercial Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Services

Health Services

Electronic Technology

Health Technology

Technology Services

Finance

Health Services

Technology Services

Commercial Services

Finance

Mckinsey & Co., Inc. (Munich)

  1. Mercati
  2. Insiders
  3. Karl Swartling
-40%: Proroga eccezionale
g
:
:
ENTRA ORA